{
    "success": true,
    "data": {
        "ucits": true,
        "type": "ETP",
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": true,
        "replication_method": "synthethic",
        "complex_factors": "Leverage, Synthetic Replication, Index that provides a total return exposure to -3 times the daily performance of AstraZeneca PLC",
        "classification": "complex",
        "supporting_data": "This GraniteShares ETP is classified as complex under MiFID II due to several factors. Firstly, it employs a 3x short leveraged strategy, meaning it seeks to provide returns that are -3 times the daily performance of AstraZeneca PLC. This leverage, although not directly through borrowing, is achieved using derivatives and introduces significant complexity and risk. Secondly, the ETP replicates its index performance synthetically using swaps. This introduces counterparty risk (Natixis, the Swap Provider), which is difficult for retail investors to understand. The KID explicitly states that the product is not simple and may be difficult to understand. The daily reset of leverage adds further complexity through a compounding effect, making returns over periods longer than one day deviate significantly from the underlying asset's performance multiplied by the leverage factor. This can cause substantial losses due to volatility. The reliance on a swap provider also creates the need for collateralization, further increasing complexity. The summary risk indicator classifies the product as having the highest risk level (7 out of 7), which also points towards complexity. The product is not capital protected and the compounding effect and daily reset imply a complex structure."
    }
}